Christopher Howe analyst

Currently out of the existing stock ratings of Christopher Howe, 91 are a BUY (93.81%), 6 are a HOLD (6.19%).

Christopher Howe

Work Performance Price Targets & Ratings Chart

Analyst Christopher Howe, carries an average stock price target met ratio of 56.24% that have a potential upside of 33.25% achieved within 283 days. Previously, Christopher Howe worked at BARRINGTON, B. RILEY.

Christopher Howe’s has documented 194 price targets and ratings displayed on 17 stocks. The coverage was on Technology, Industrials, Consumer Cyclical, Basic Materials, Healthcare sectors.

Most recent stock forecast was given on SRT, StarTek at 10-Oct-2023.

Wall Street Analyst Christopher Howe

Analyst best performing recommendations are on SRTS (SENSUS HEALTHCARE).
The best stock recommendation documented was for CALX (CALIX) at 10/26/2021. The price target of $73 was fulfilled within 13 days with a profit of $14.93 (25.71%) receiving and performance score of 19.78.

Average potential price target upside

CALX Calix CMCO Columbus McKinnon CVGI Commercial Vehicle Group HI Hillenbrand HSC Enviri KAI Kadant SXI Standex International TACT TransAct Technologies CMBM Cambium Networks Corp HLIO Helios Technologies MEI Methode Electronics MIMO Airspan Networks Holdings SRT StarTek CSWI CSW Industrials KOP Koppers Holdings SRTS Sensus Healthcare WWD Woodward

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 12-Apr-2022

$55

$19.04 (52.95%)

$55

1 months 19 days ago
(23-Jul-2026)

12/30 (40%)

$19.23 (53.76%)

219

Buy Since 16-Apr-2026

$58

$22.04 (61.29%)

$65

1 months 20 days ago
(22-Jul-2026)

6/11 (54.55%)

$22.16 (61.83%)

31

Hold Since 21-Jul-2026

$52

$16.04 (44.61%)

$52

1 months 21 days ago
(21-Jul-2026)

12/16 (75%)

$13.65 (35.59%)

230

Buy Since 22-Jun-2021

$62

$26.04 (72.41%)

$70

4 months 19 days ago
(23-Apr-2026)

17/30 (56.67%)

$19.31 (45.23%)

185

Buy Since 29-Jan-2022

$75

$39.04 (108.57%)

$68

10 months 11 days ago
(31-Oct-2025)

14/15 (93.33%)

$6.58 (9.62%)

369

Show more analysts

Please expand the browser size to see the chart

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?